APEN News and Press, Apollo Endosurgery Inc. From 08/31/20

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

LOS ANGELES, CA / ACCESSWIRE / August 26, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it will present at the LD 500 investor conference on Wednesday, September...

LOS ANGELES, CA / ACCESSWIRE / August 5, 2020 / LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. "For the first time in ten years, we were unable to host our mid-year conference, which ...

Apollo Endosurgery (NASDAQ: APEN ) : Q2 GAAP EPS of -$0.30 beats by $0.03 . More news on: Apollo Endosurgery, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / August 4, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced financial...

AUSTIN, TX / ACCESSWIRE / July 30, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that the Company is scheduled to release its financial results for the second quarter e...

Apollo Endosurgery (NASDAQ: APEN )   +2.8%  pre-market announces private placement of shares and and pre-funded warrants for gross proceeds of $25M More news on: Apollo Endosurgery, Inc., Healthcare stocks news, Earnings news and commentary, , , Read more ...

AUSTIN, TX / ACCESSWIRE / July 20, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that it has entered into definitive agreements for a $25 million equity financing. Conc...

Apollo Endosurgery (NASDAQ: APEN ) has submitted a 510(k) application to the FDA seeking clearance of its X-Tack Endoscopic HeliX Tracking System, a through-the-scope suture-based device designed for closing defects in the lower GI tract with additional applications in the upper GI tract. ...

AUSTIN, TX / ACCESSWIRE / July 7, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the 510k submission of the X-Tack™ Endoscopic HeliX Tacking System to the U.S. Fo...